Several studies have pointed out that L-selectin on CD34-positive cells plays a role in haematopoietic reconstitution after peripheral blood stem cell (PBSC) transplantation. Since it is known that a decrease in L-selectin expression in lymphocytes and granulocytes can be induced by a variety of stress situations, we have investigated in this study whether the freeze-thawing procedure, used in PBSC transplantation, would affect L-selectin expression on CD34 + stem cells. 
bation in all samples. Both the loss of L-selectin expression on CD34 cells occurring upon freeze-thawing, the emergence of apoptosis, as well as the recovery of L-selectin expression on non-apoptotic cells varies largely between individual leucapheresis samples, and therefore it is concluded that such processes should be considered when correlations with clinical outcome after transplantation are made. Keywords: L-selectin; cryopreservation; CD34 ϩ ; peripheral blood stem cells
The use of high-dose chemotherapeutic (myeloablating) schemes in haematologic malignancies and solid tumours has raised the need for haematologic rescue. After the mobilization of haematopoietic stem cells by G-CSF and/or chemotherapy, cells are harvested by means of leucapheresis. The leucapheresis material is processed and subsequently cryopreserved until reinfusion after high-dose chemotherapy.
In the leucapheresis material (transplantation material) the multipotent progenitor cells are generally thought to reside within the CD34-positive population. These cells are thought to return to the bone marrow after the reinfusion, a process which is called homing. 1 Factors that might affect homing include the expression of adhesion molecules. 2, 3 Indeed, the adhesion molecule L-selectin (CD62L) seems to play a role in haematopoietic reconstitution after stem cell transplantation. [4] [5] [6] [7] [8] [9] Whether this can be assigned to a role in the homing process itself or is due to a stem cell population with specific biologic or differentiative properties is not yet clear.
L-selectin is an adhesion molecule of the selectin family with the members E, P and L-selectin.
10-14 L-selectin is expressed throughout myeloid differentiation and plays a role in the recruitment of leukocytes to inflammatory sites. It is the major homing receptor of lymphocytes and is important for rolling over the high endothelial venules. A variety of stress situations can cause a decrease in L-selectin expression (shedding) in lymphocytes and leukocytes. [15] [16] [17] [18] [19] [20] [21] Since cryopreservation may be considered as a stress factor we hypothesized that the freeze-thawing process might change L-selectin expression and thereby indirectly affect the homing ability of CD34 ϩ progenitor cells. In the present study FACS analysis was used to determine the freeze-thawing effect on the L-selectin expression on CD34 cells. In addition, since previous experiments had shown that the freeze-thawing procedure causes apoptosis L-selectin expression on CD34 + PBSCs F De Boer et al 1104 in purified CD34 ϩ progenitor cells, 22 we have attempted to link both processes, indicative for damage to cells.
Materials and methods

Patient material
Peripheral blood stem cells of patients with haematologic malignancies or solid tumours were harvested by means of leucapheresis after peripheral stem cell (PSC) mobilization. For solid tumours the mobilization procedure consisted of chemotherapeutic treatment (5-fluorouracil, epidoxorubicin, cyclophosphamide) followed by daily subcutaneous injection of granulocyte colony-stimulating factor (G-CSF 10 g/kg, Filgrastim; Amgen, Thousand Oaks, CA, USA) or G-CSF (15 g/kg) alone until completion of the leucapheresis. For the haematologic malignancies mobilization was accomplished by chemotherapeutic treatment consisting of IMVP (ifosfamide, methotrexate, VP16) and (from day 8) daily subcutaneous injection of G-CSF (10 g/kg). Whole blood samples were collected immediately before leucapheresis and fresh leucapheresis samples were withdrawn from the harvest directly after leucapheresis. The unpurified samples for the incubation experiments were taken from the leucapheresis harvest after processing and cryopreserved in parallel in autologous plasma with 10% DMSO (Dimethylsulfoxide; Acros Organics, NJ, USA). For CD34 ϩ isolation and kinetic experiments the samples were either directly drawn from the harvest with subsequent isolation and cryopreservation of CD34 ϩ cells or drawn from a leucapheresis bag immediately after thawing with subsequent isolation of CD34 cells from part of the sample. The CD34 percentage in the starting material was 1.4 (range 0.46-5.6%).
Isolation of CD34-positive cells
For isolation of the CD34-positive cells from leucapheresis material the MACS isolation kit (Miltenyi, Bergisch Gladbach, Germany) was used according to the manufacturer's instructions. Briefly, prior to the magnetic isolation red cells were lysed with ammonium chloride for 8 min followed by two washing steps with PBS/0.1% BSA. After blocking (human Ig, FcR blocking reagent) the mononuclear cells were indirectly labelled using a hapten-conjugated CD34 monoclonal antibody (Qbend/10) and an antihapten antibody coupled to MACS microbeads. During all these steps cells were kept on ice. Subsequently, the magnetically labelled cells were washed with MACS buffer (PBS/5 mm EDTA/0.5% BSA) and enriched on positive selection columns (type LSϩ or MSϩ). After the MACS procedure the purity of the CD34-positive cells was always more than 90% as determined by FACS analysis (see next paragraph). 
Flow cytometry
Cell culture
Cryopreserved leucapheresis or purified CD34 samples were rapidly thawed by dilution (1:10) in PBS/0.1% BSA kept at 37°C (Sigma, St Louis, MO, USA) and containing 250 g DNAse/ml (Boehringer Mannheim, Mannheim, Germany) to prevent clotting. In experiments in which the CD34 ϩ isolation was undertaken after cryopreservation, samples were drawn from the transplant bag, handled in a similar way and purified as described before. For cell culture, after centrifugation (5 min, 400 g) the cells were resuspended at 0.5 ϫ 10 6 /ml in RPMI 1640 without phenol red (Life Technologies, Paisley, UK) supplemented with 2 mm l-glutamine, 100 U/ml penicillin, 100 g/ml streptomycin and 10% FBS (Life Technologies) and incubated at 37°C at 5% CO 2 Aliquots of the purified or unpurified cells were harvested at different time points of incubation for FACS analysis.
Statistical analysis
For analysis, SPSS (Statistics Package of the Social Sciences, SPSS Inc., Chicago, IL, USA) software was used. Data were summarized by means and standard deviation. Differences were determined according to the Student's ttest for paired samples. A P value lower than 0.05 was considered significant.
Results
Changes in marker expression on CD34 ϩ cells caused by cryopreservation
In Table 1 an overview is given of the effect of cryopreservation on CD34 ϩ subpopulation marker expression. Consistent loss of marker expression can be observed for the adhesion molecule CD62L (L-selectin). Also the expression of CD117 (c-Kit) decreased upon cryopreservation. For the other markers determined the changes found were not consistent.
Considering the suspected importance of L-selectin in bone marrow reconstitution we have examined L-selectin expression in more detail, starting with whole blood before leucapheresis until the moment of reinfusion.
L-selectin expression on CD34 + cells in whole blood and leucapheresis material
Since L-selectin shedding can occur due to stress factors we first determined if the leucapheresis procedure itself is such a stress factor. L-selectin expression on CD34 cells was analysed by FACS in samples of whole blood before leucapheresis and in samples of leucapheresis material of the same patients. In 11 cases tested a small to moderate decrease in L-selectin expression was seen with a mean difference between whole blood and leucapheresis samples of 11.9% (range 6-23%, P Ͻ 0.001). In addition, in the whole blood samples two L-selectin populations with a low and high expression could be distinguished while in the leucapheresis samples this distinction was less clear due to the loss of L-selectin expression. In the next experiments only the total L-selectin expression was analysed. Table 1 Effect of cryopreservation on marker expression in CD34
a Depicted are the percentages of CD34 ϩ subpopulations (marker expression) in fresh leucapheresis material (first figure) compared to the percentages after cryopreservation (last figure) . b The figures between brackets represent the absolute percentage decrease in marker expression. ND = not determined.
Comparison of CD34 + L-selectin expression in leucapheresis material before and after cryopreservation
To further explore the effect of cryopreservation on the Lselectin expression of CD34 cells in transplants, additional samples of leucapheresis material were rapidly thawed. The L-selectin expression was assessed directly after thawing by FACS analysis and compared with the L-selectin expression in the fresh leucapheresis material of the same patients.
In most samples a moderate to large decrease in Lselectin expression was seen with a mean of 39% after cryopreservation ( Table 2) . Similar results were found for cryopreserved CD34 ϩ cells purified before freezing (mean decrease 41%; range 20-84%, n = 5 experiments, data not shown).
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Re-expression of L-selectin expression on CD34 + cells after culturing of thawed samples
To determine if L-selectin can be re-expressed on CD34 ϩ cells, 11 samples of thawed leucapheresis material were incubated overnight at 37°C in RPMI/10% FCS and analysed by FACS. During incubation two CD34-positive populations appeared in the blast region differing in forward scatter which was most prominent after overnight incubation (Figure 1) . Staining of incubated samples with the viability stain 7-AAD revealed that the population with the low forward scatter (population 1) was partly 7-AAD positive (non-viable) but also partly 7-AAD negative, while the population with the high forward scatter (population 2) was 7-AAD negative. Parallel experiments in our laboratory in which Syto 16 was used as an apoptosis marker 22, 23 together with 7-AAD staining showed that the part of population 1 with the low FSC that was 7-AAD negative had a relatively low Syto 16 staining which is indicative for early apoptosis. Population 2 is considered to be relevant for clinical recovery and varied largely between individual samples. The incidence of the non-viable population 1 as a percentage of the whole CD34 ϩ population varied from a few (ND = non-detectable) percentages to 90% after overnight incubation (Table 3) . Considering the percentage of CD34 ϩ cells positive for L-selectin, an increase of expression (minimally 10%) was observed after overnight incubation of the thawed leucapheresis material in eight out of 11 samples in the relevant population 2 and in nine out of nine samples in population 1 (Figure 2, Table 3 ). When the percentage of L-selectin expression on CD34 ϩ cells as found in Table 3 in fresh leucapheresis material was set at 100% the increase of L-selectin expression on population 2 was up to values of 46-140%. Moreover, the fluorescence intensity (MFI) increased in nine out of the nine samples tested. Remarkably, while the percentage of the population 2 CD34 cells positive for L-selectin had decreased in sample 13 and 14 and remained unchanged in sample 7 after overnight incubation, the total fluorescence (MFI) in these samples clearly increased. Depicted are the percentages of CD34 ϩ L-selectin expression and the mean fluorescence intensity (MFI) in leucapheresis samples directly after thawing (t = 0 h) and after overnight incubation (t = 24 h) in RPMI/10% FCS 37°C/5% CO 2 . a For explanation of population 1 and 2, see Figure 1 . b The ratio of population 1 and population 2 after overnight incubation which refers to the relative numbers of both populations as defined in Figure 1 . c cϾ; the fluorescence intensity of the control is higher than the fluorescence of the (anti) L-selectin Moab (due to some aspecific events with high fluorescence); no MFI calculation is possible. d Significant difference in % L-selectin in cryopreserved samples immediately after thawing and after an additional 24 h incubation (pop 2); s.e. shown). After overnight incubation in our in vitro system a random loss of total cells occurred of 54% (range 40-70%), but no preferential loss of CD34 ϩ cells was observed (not shown). Incubation at 4°C of thawed leucapheresis samples (patients 5, 6 and 9 from Table 3 ) failed to show an increase in CD34 ϩ L-selectin expression, indicating that the latter is due to a metabolic process (data not shown).
5.9, paired t-test
Since homing of stem cells is thought to occur within hours after transplantation 24, 25 we speculated that a L-selectin re-expression in vivo should occur shortly after the reinfusion of the cells. Therefore, kinetic experiments with incubation periods shorter than 24 h were performed (Table  4) . In eight different samples of leucapheresis material Lselectin expression on CD34 ϩ cells was determined before In four additional experiments we determined kinetics of L-selectin (re-)expression on CD34 cells purified before or after cryopreservation and compared this with the unpurified leucapheresis samples (patients 18, 19, 20, 21) . In sample 20 both fractions failed to show an increase in CD34 ϩ L-selectin expression. In samples 18, 19 and 21 the purified fraction showed a faster L-selectin re-expression (within 4 h); whether this is due to inhibiting effects of the accessory cells present in the unpurified samples, remains to be elucidated.
Changes of L-selectin expression due to purification of fresh leucapheresis material
During the experiments comparing frozen purified CD34 ϩ cells with frozen whole leucapheresis material it was observed that upon purification of fresh leucapheresis samples significant losses of L-selectin could occur. In contrast to the situation with frozen-thawed samples clear reexpression of L-selectin was always seen after overnight incubation in RPMI/10% FCS in 10 out of 10 experiments in which CD34
ϩ isolation was performed (data not shown). In the five samples tested for re-expression at a shorter time interval a (nearly) complete L-selectin re-expression occurred within 4 h of incubation in all samples after the initial decrease caused by the purification method ( Table  5 ). The same observations were made when another anti-L-selectin monoclonal antibody was used (Dreg 56). In contrast, no change in viability or cell loss was observed (not shown). These findings suggest another pathway of % of L-selectin expression immediately before ('fresh') or after (t = 0) the MiniMACS procedure and at different time points of the subsequent incubation in RPMI/10% FCS (t = 0, 2, 4, 24 h). ND = not determined.
down-/up-regulation of CD34 ϩ L-selectin compared to the down-/up-regulation found after cryopreservation.
Discussion
In the present study we have shown that the freeze-thawing process which is part of the peripheral stem cell transplantation procedure results in a loss of quality of the transplant. This was reflected by a significant decrease of L-selectin expression on CD34 ϩ stem cells on the one hand and the presence of an apoptotic cell population on the other hand. With respect to the first observation the loss of L-selectin might negatively influence haematopoietic recovery since selectins are thought to play a role in the homing process to the bone marrow. Assuming such a role for L-selectin, a median loss of roughly 54% L-selectin-positive CD34 ϩ cells/kg (Table 2 and as exemplified in more detail in the results section for 10 patients), might have important consequences for haematopoietic recovery, especially when transplants with low numbers of CD34 ϩ cells are reinfused. We hypothesized that in vivo rapid L-selectin re-expression might take place after reinfusion of the thawed transplant. We tried to address the question of re-expression of L-selectin by overnight incubation of leucapheresis material in vitro. It appeared that the percentage of L-selectin on CD34 ϩ cells as well as the mean fluorescence intensity increased in most of the samples. Nevertheless, additional experiments revealed that L-selectin increase on the relevant population within shorter incubation periods was found only in a minority of cases. In some of the cases accessory cells in unpurified samples seemed to negatively influence L-selectin recovery; however, this may be an in vitro artefact since it can be speculated that in vivo these accessory cells possibly have only a minor effect on CD34 ϩ L-selectin up-regulation due to the huge dilution occurring in blood after the reinfusion of the cells.
The loss of CD34 ϩ L-selectin expression after freezethawing and the large variation in re-expression, together with our second observation, the occurrence of two populations (apoptosis), might be important factors affecting the homing ability of the stem cells and therefore eventually the clinical recovery. These findings must therefore be taken into account when correlations with clinical recovery are being made. Since only a proportion of the patient group studied in the present paper actually has been transplanted it is too early to draw conclusions. In a previous study by Dercksen et al 5 a positive correlation was found between the number of reinfused CD34 ϩ L-selectinϩ cells as measured on thawed leucapheresis samples and haematopoietic recovery). In that study, however, the number of reinfused CD34
ϩ L-selectinϩ cells was calculated using the number of CD34 ϩ cells found in the fresh leucapheresis material assuming that the latter had not been influenced by cryopreservation. From our study it appears that dramatic differences between patients exist with regard to apoptosis and L-selectin re-expression. For the clinic this means that in some cases the total number of reinfused CD34
ϩ cells might eventually turn out to be too low to ensure that a sufficient number of cells will engraft. Predictions of CD34 ϩ (subpopulations) actually reinfused should then be made by analysing the frozen-thawed transplant.
Considering the effects of the freeze-thawing process on the quality of PBSCs it is of interest to compare the recovery with a transplantation procedure using unprocessed G-CSF stimulated whole blood after high-dose chemotherapy. 26, 27 Most remarkable in this whole blood procedure, in which no freeze-thawing takes place, is the fact that only small numbers of CD34 ϩ cells are reinfused compared to the PBSC transplantation procedure with leucapheresis material while a comparable haematologic recovery is still achieved. One might therefore speculate that in the whole blood procedure the quality of the transplant is preserved better. The comparison of the quality of progenitors present in whole blood and in thawed PBSC transplants is the subject of a present study.
Apart from the freeze-thawing process CD34 purification (MiniMACS) could also induce a marked decrease in L-selectin expression. This finding is of interest since the use of magnetic CD34 ϩ isolation in the clinical setting is increasing. 28 Most remarkable was the consistent quick L-selectin re-expression on CD34 cells after the loss induced by the magnetic purification method. The differences in this respect with the freeze-thawing process suggest that additional damage occurs due to cryopreservation. Furthermore, we cannot exclude the possibility that the loss of L-selectin in the magnetic purification procedure is based on internalization instead of shedding by enzymatic cleavage suggested above by us for the freeze-thawing process. This would explain why re-expression occurred within 2 h of incubation after loss. These hypotheses are presently being studied in our laboratory. Other experiments in which the phenomenon described in the present paper may play a role include the study of Watanabe et al 4 in which Lselectin expression was determined on CD34 cells purified by MiniMACS. Although a positive correlation was found between the calculated number of CD34 ϩ L-selectinϩ cells and haematologic recovery, the number of homing L-selectinϩ cells may be different from the number of calculated reinfused CD34 ϩ L-selectinϩ cells Furthermore, in a clinical study of Hohaus et al 29 reinfusion of CD34 ϩ PBSCs which had lost their L-selectin expression by magnetic purification led to a good haematologic recovery. It might be speculated that in this study in vivo recovery of L-selectin expression may have taken place.
In the literature, L-selectin regulation on lymphocytes and granulocytes mainly involves down-regulation (shedding) at the cell surface. Such shedding can be triggered through multiple independent intracellular signalling pathways induced by activators such as PMA, GM-CSF, TNF, FMLP or by cross-linking with Leu 13. [15] [16] [17] [18] [19] [20] [21] Spontaneous expression of L-selectin on selected L-selectinnegative murine bone marrow cells by culturing in medium alone has been described by Salmi and Jalkanen. 30 Similar observations were made by Tedder et al 31 during prolonged culture of splenic B cells or T cells. A quick increase of L-selectin expression after a decrease induced by crosslinking of CD45 has been described on lymphocytes, 16 but so far such observations have not been done for CD34 ϩ cells.
If L-selectin on CD34 ϩ cells does indeed play a role in the first steps of homing (rolling), one could speculate that in the in vivo situation factors such as chemokines lead to a quick up-regulation after reinfusion of the cells or alternatively that only a low L-selectin expression is needed. Besides, although we proved with our experiments that Lselectin re-expression was possible by incubation after thawing, overnight incubation of transplants at present is not recommended since in our in vitro incubation conditions a random loss of cells was seen. This would counteract the beneficious up-regulation of L-selectin.
Apart from its role in cell-interaction it is also possible that L-selectin plays a role in the outgrowth of CD34 ϩ cells [6] [7] [8] and therefore that availability of the molecule is (only) needed in the bone marrow. For these reasons we are presently undertaking functional studies to unravel the role of L-selectin in PBSC transplantation by performing adhesion studies under conditions of flow 32 and clonogenic assays with L-selectin-positive CD34 cells. With this approach the effect of freeze-thawing and CD34 ϩ purification on the functional capacities of the CD34 cells will thus be studied.
Although the relevance of changes in expression of other markers such as CD117, stem cell factor receptor, is not yet clear, their involvement in stem cell expansion and apoptosis warrants further study.
It is concluded that, in addition to apoptosis induction, the freeze-thawing procedure and a CD34 purification method used in the transplantation setting affect the phenotype of CD34
ϩ PBSCs. Such findings should be taken into consideration when correlations with clinical outcome are being made. In addition, special attention should be paid to the 'dynamic' character of L-selectin expression on CD34 ϩ cells when in vitro or in vivo studies are performed.
